Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 39, Issue 6, June 2014, Pages 385-447
 
MONOGRAPHS
 
  
 Beloranib hemioxalate.
Methionine aminopeptidase 2 inhibitor, Treatment of obesity.
Gras, J.
Drugs Fut 2014, 39(6): 385
Summary | Full Text: PDF 
 
  
  
 Deleobuvir sodium.
RNA-directed RNA polymerase (NS5B) inhibitor, Antiviral agent.
Reviriego, C.
Drugs Fut 2014, 39(6): 391
Summary | Full Text: PDF 
 
  
  
 Onartuzumab.
Anti-HGFR (c-Met) monoclonal antibody, Oncolytic.
Arriola, E., Conde-Estevez, D.
Drugs Fut 2014, 39(6): 403
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Genetic models mimicking human diseases.
Vila, R., Castaner, R., Cole, P.
Drugs Fut 2014, 39(6): 409
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Navarro, D., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2014, 39(6): 423
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 Annual Meeting of Experimental Biology (ES), San Diego, California, USA – April 26-30, 2014.
Abalia, J.O.
Drugs Fut 2014, 39(6): 429
Summary | Full Text: PDF 
 
  
  
 Association for Research in Vision and Ophthalmology (ARVO), Orlando, Florida, USA – May 4-8, 2014.
Forns, N.
Drugs Fut 2014, 39(6): 433
Summary | Full Text: PDF 
 
  
  
 105th Annual Meeting of the American Association for Cancer Research (AACR), San Diego, California, USA – April 5-9, 2014.
Mila, M., Prieto, M., Shamahi, A.
Drugs Fut 2014, 39(6): 439
Summary | Full Text: PDF 
 
  
  
 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain &ndash, May 10-13, 2014.
Pina, P.
Drugs Fut 2014, 39(6): 445
Summary | Full Text: PDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy